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4We are pleased to present the key findings of the 2011 European school 
survey report produced by the European School Survey Project on Alcohol 
and Other Drugs (ESPAD). ESPAD is a collaborative network of independent 
research teams in more than forty European countries and the largest cross-
national research project on adolescent substance use in the world. This 
extended summary includes the summary of the ESPAD report as well nine 
extra graphs and one extra table. We are making it available electronically 
in 23 languages and in printed form in four to ensure wide dissemination of 
the findings across Europe. The summary serves as a complement to the full 
report that is available in English.
This multilingual summary is a product of the ever-strengthening cooperation 
that exists between the EMCDDA and ESPAD. Our common aims are: to 
broaden access to the information and expertise on alcohol and other drug 
use among school students developed by the ESPAD project; to improve the 
availability, quality and comparability of school survey data; and to gain 
maximum analytical insight from the data available in this area.
The mandate of the EMCDDA is to collect, analyse and disseminate factual, 
objective, reliable and comparable information on the European drug 
situation. Collaboration with European and international organisations in 
the drugs field is central to the work of the EMCDDA as a means of 
enhancing understanding of the global drugs phenomenon.
ESPAD data have become an increasingly important component of the 
EMCDDA’s reporting and provide valuable information for obtaining the 
European picture on younger people. The ESPAD project ensures a common 
approach to collecting information on substance use among 15- to 16-year-
old students in Europe and allows trends over time to be assessed. This is 
the second multilingual summary supported by the EMCDDA. The agency 
has also provided financial assistance for ESPAD school survey data 
collections in six Balkan countries through the Instrument of Pre-accession 
Assistance (IPA).
We would like to take this opportunity to thank all the governmental and 
non governmental partners in ESPAD countries that contributed to the 
funding, data collection, analysis and dissemination of this important work. 
The work of the ESPAD project would not have been possible without the 
generous support of the Swedish Ministry of Health and Social Affairs.
Wolfgang Götz, Director, EMCDDA
Björn Hibell, ESPAD Coordinator
Foreword
5Data are collected by group-administered 
questionnaires. The students answer the 
questionnaires anonymously in the classroom with 
teachers or research assistants functioning as survey 
leaders. The 2011 samples of classes are nation ally 
representative, except in four cases: in Belgium the 
study was performed in the Dutch-speaking part 
(Flanders) only, in Bosnia and Herzegovina it covered 
only the entity of the Republic of Srpska, in Germany 
only five out of sixteen federal states (Bundesländer) 
participated, and data collection in the Russian 
Federation was restricted to the city of Moscow.
The content of the present international report is 
based on standardised country reports and data sets 
delivered to the ESPAD Coordinators and Databank 
Manager. A few countries have experienced modest 
problems of a methodological kind, but not of such a 
magnitude as to seriously threaten the com parability 
of the results, and the overall validity is deemed to be 
high for most countries even though it should be 
recognised that the national cultural context in which 
the students have answered the questions has most 
certainly varied. As a precautionary measure related 
to low school-participation rate, the comparability of 
data from the United Kingdom has been deemed to 
be limited.
National sample sizes were most often close to or 
above the number of classes that should make it 
possible to reach the recommended number of 2 400 
participating students. Exceptions to this are the 
smallest countries, where the num bers were smaller 
even though all relevant students were sur veyed.
Small differences in point estimates between 
countries or over time should be interpreted with 
caution. Changes within countries between 2007 
and 2011 have been tested for sta tistically significant 
differences, while changes below four percentage 
points between previous data collections are not 
recognised as real changes. Differences in 2011 
between boys and girls have also been tested for 
statistically significant dif ferences at the country level.
The main purpose of the European School Survey 
Project on Alcohol and Other Drugs (ESPAD) is to 
collect comparable data on substance use among 
15- to 16-year-old European students in order to 
monitor trends within as well as between countries. 
So far, five data-collection waves have been 
conducted in the framework of the project. The first 
study was carried out in 26 countries in 1995, while 
data collection in 2011 was performed in 37 
countries. However, results for 2011 are available 
only for 36 countries, since the Isle of Man collected 
data but unfortu nately did not have the possibility to 
deliver any results.
This summary presents key results from the 2011 
survey in the ESPAD countries as well as findings 
regarding the long-term trends. An initial section 
gives a short overview of the method ology.
Independent research teams in the participating 
countries form the basis of the collaborative project. 
In the 2011 ESPAD data collection, more than 
100 000 students took part in the following 
countries: Albania, Belgium (Flanders), Bosnia and 
Herzegovina (Republic of Srpska), Bulgaria, 
Croatia, Cyprus, the Czech Republic, Denmark, 
Estonia, the Faroe Islands, Finland, France, 
Germany (five Bundesländer), Greece, Hungary, 
Iceland, Ireland, the Isle of Man, Italy, Latvia, 
Liechtenstein, Lithuania, Malta, Moldova, Monaco, 
Montenegro, Norway, Poland, Portugal, Romania, 
the Russian Federation (Moscow), Serbia, Slovakia, 
Slovenia, Sweden, Ukraine and the United 
Kingdom.
Methodology and data quality
To provide as comparable data as possible, the 
surveys are conducted with common questionnaires 
and according to a standardised methodology. Data 
are mainly collected during the spring, and the 2011 
target population was students born in 1995, with a 
mean age of 15.8 years at the time of data  
col lection.
Summary
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observed for past-30-days cigarette use between 
1999 and 2007, but the situa tion remained 
unchanged in 2011 compared with 2007.
Between the two most recent surveys, the proportion 
of students who had been smoking during the past 
30 days in creased significantly in seven countries 
and fell in five. Some of the increases were fairly 
striking, with 13 percentage points in Monaco and 
10 in Portugal. Compared with 1995, the countries 
with the largest decreases (20 percentage points or 
more from the start) are Iceland, Ireland and 
Norway. No country shows a continuous increase 
across the five waves.
Alcohol
In all ESPAD countries but Iceland, at least 70 % of 
the students have drunk alcohol at least once during 
their lifetime, with an average of 87 % in the 2011 
survey. The corresponding aver age figures for use in 
the past 12 months and the past 30 days are 79 % 
and 57 %, respectively. For all three time frames, 
there were small decreases from 2003 through 2007 
to 2011. Of course, these averages are based on 
highly divergent coun try figures. For example, alcohol 
use during the past 30 days was reported by more 
than 75 % of the students in the Czech Republic and 
Denmark, but only by 17 % in Iceland and 32 % in 
Albania. There is no clear geographical pattern but 
coun tries with relatively small proportions are mainly 
found among Nordic and Balkan countries.
The national average figures for lifetime, past-12-
months and past-30-days prevalence are about the 
same for boys and girls, but when differences occur 
the prevalence is nearly always higher among boys. 
To give an example: in 15 countries there are 
significantly more boys than girls who have been 
drinking during the past 30 days, while girls are in 
the majority only in three (Iceland, Latvia and 
Sweden). Moreover, when it comes to more frequent 
drinking within each time frame, the proportions are 
usually higher among boys.
Of the students who reported the amounts of various 
bever ages that they consumed during the most recent 
day on which they drank alcohol, the estimated 
average consumption differed between the sexes, 
with boys drinking one-third more than girls (2011 
Results from 2011 for eight key variables are presented 
in a summary table below, in which significant 
decreases com pared with 2007 are marked with 
green and corresponding increases with red.
Cigarettes
A small number of questions regarding cigarette 
smoking are asked at the beginning of the 
questionnaire. In the 2011 sur vey, on average, 54 % 
of the students in participating countries reported that 
they had smoked cigarettes at least once and 28 % 
that they had used cigarettes during the past 30 
days. Two per cent of all students had smoked at 
least a packet of cigarettes per day during the past 
30 days.
The ranking orders of countries for lifetime use and 
relative ly recent use (past 30 days), respectively, are 
more or less the same. High-prevalence countries for 
cigarette use in the past 30 days include Bulgaria, 
Croatia, the Czech Republic, France, Latvia, Monaco 
and Slovakia (at around 40 %) and the low-
prevalence countries are Albania, Iceland, 
Montenegro and Norway (at around 12 %). There is 
no obvious geographical pat tern to be seen.
In countries where more students smoke, students are 
also more likely to report that cigarettes are easily 
obtainable. An early smoking debut (age 13 or 
younger) is associated, at the aggregate country 
level, with high levels of use in the past 30 days. On 
average, 7 % of the students said that they had 
smoked cigarettes on a daily basis at the age of 13 
or younger.
At the aggregate country level, the sex differences in 
2011 are negligible for smoking in the past 30 days 
while a small gap, with more boys who are smokers, 
was visible in 1995 and 1999. However, in individual 
countries large sex differences may be observable in 
2011 as well. There were significant dif ferences 
between boys and girls in eleven countries, with 
higher figures for boys in six and for girls in five.  
For example, boys were about 16 percentage points 
above girls in Albania, Cyprus and Moldova while, 
conversely, girls were about 15 percentage points 
above boys in Bulgaria and Monaco.
In the countries for which there are data from all five 
sur veys, a drop of 7 percentage points can be 
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2011 (43 %) than it was in 2007 (45 %) and thus 
also relatively close to the 1995 figure (41 %).
The average gender gap has shrunk from 12 
percentage points in 1995 to 5 in 2011, but even in 
the latest survey sig nificantly more boys than girls 
reported heavy episodic drinking in 22 of the ESPAD 
countries. However, in one country (Sweden) the 
proportion was significantly higher among girls. 
Another three of the Nordic countries (Finland, 
Iceland and Norway) belong to the group of ten 
ESPAD countries in which the figures in 2011 were 
about the same for girls as for boys. The other  
coun tries in this group are the two British Isles countries 
— Ireland and the United Kingdom (limited 
comparability) — the neighbouring countries of 
France and Monaco, and a few other countries in 
different parts of Europe (Belgium, Flanders; Estonia; 
and the Russian Federation, Moscow).
Two Nordic countries are at opposite ends of the 
scale when it comes to heavy episodic drinking. The 
proportion of students in Iceland who reported in 
2011 that they had engaged in this behaviour during 
the past 30 days was 13 %, while it was more than 
four times higher in Denmark (56 %). A look at the 
map does not indicate any clear geographical 
pattern.
Between the two most recent surveys, the figures for 
heavy episodic drinking increased significantly in 
four countries (Cyprus, Greece, Hungary and Serbia) 
while a significant fall can be seen in nine countries 
with comparable data, including the four Nordic 
countries of the Faroe Islands, Iceland, Norway and 
Sweden. The largest increases, of about 10 
percentage points, occurred in Cyprus and Hungary, 
while the largest decreases, of 9 percentage points, 
took place in the Faroe Islands and Iceland.
On average, nearly six in ten students had consumed 
at least one glass of alcohol at the age of 13 or 
younger and 12 % had been drunk at that age. This 
reply was given, on average, by more boys than 
girls, and that tendency was the same in almost all 
countries.
A number of students reported having had problems 
during the past 12 months linked to their alcohol 
consumption. The types of problem most commonly 
reported were ‘performed poorly at school or work’ 
averages of 5.8 versus 4.3 centilitres of 100 % 
alcohol). A significant difference in this direction can 
be found in nearly all countries. However, in a 
couple of countries (Iceland and Sweden) the 
average quantities were about the same among girls 
as among boys. In a large majority of the countries, 
beer is the dominant beverage among boys. Spirits is 
the most impor tant beverage among girls in just over 
half of the countries. On average, these two 
beverages together account for about 70 % of the 
students’ total consumption.
There are huge differences between countries. On 
their most recent drinking day, Danish students, on 
average, drunk more than three times as much as 
students in Albania, Moldova, Montenegro and 
Romania. Large quantities are mainly found among 
students in the Nordic and British Isles countries, 
while countries with smaller quantities are often 
located in south-eastern Europe. The average 
quantities consumed on the latest drinking day were 
about the same in 2011 as in 2007. At the national 
level, however, they increased significantly in 2011 in 
ten countries but dropped in only four.
At the country level, there is no (statistical) correlation 
be tween the proportion of students in a country who 
had been drinking during the past 30 days and the 
amounts consumed on the latest drinking day. This 
means that both high and low average levels of 
consumption in volume terms can be found in 
countries with either high or low drinking frequencies.
There is a strong association at the country level 
between re ported alcohol consumption on the latest 
drinking day and the perceived level of intoxication 
on that day. Thus, in countries where students 
reported that they consumed larger quantities of 
alcohol they also reported higher levels of 
intoxication.
Another way of measuring drunkenness is to ask how 
often the students had consumed five drinks or more 
on the same occasion during the past 30 days. This 
measure of ‘heavy epi sodic drinking’ has undergone 
one of the most striking changes among girls across 
the ESPAD waves, with the aggregate-level average 
increasing from 29 % in 1995 to 41 % in 2007. In 
the 2011 survey, however, this figure has dropped to 
38 %. Among boys, the figure is also slightly lower in 
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Summary table  Selected key variables by country. Percentages (if not otherwise indicated). ESPAD 2011.  
Colours indicate significant changes to the 2007 data collection
Cigarette 
use past  
30 days
Alcohol  
use past  
30 days
Heavy 
episodic 
drinking 
past 30 
daysa)
Alcohol 
volume  
(cl 100%) 
last drinking 
day, among 
consumers
Lifetime use 
of cannabis
Lifetime  
use of  
other illicit  
drugs than 
cannabisb)
Lifetime  
use of 
tranquillisers 
without 
prescription
Lifetime  
use of 
inhalantsc)
Albania 13 32 21 3.0 4 6 8 3
Belgium (Flanders) 26 69 38 4.7 24 9 8 7
Bosnia and Herz. (RS) 15 47 31 3.6 4 2 4 5
Bulgaria 39 64 48 4.0 24 10 3 4
Croatia 41 66 54 6.6 18 5 5 28
Cyprus 23 70 44 4.5 7 7 11 8
Czech Republic 42 79 54 5.6 42 8 10 8
Denmarkd) 24 76 56 9.7 18 5 4 4
Estonia 29 59 53 6.0 24 8 8 15
Faroe Islands 31 44 33 6.2 5 3 2 6
Finland 34 48 35 7.5 11 3 7 10
France 38 67 44 .. 39 10 11 12
Germany (5 Bundesl.) 33 73 .. 5.6 19 8 2 10
Greece 21 72 45 4.2 8 5 9 14
Hungary 37 61 45 5.2 19 8 9 10
Iceland 10 17 13 4.8 10 4 8 3
Ireland 21 50 40d) 6.7 18 6 3 9
Italy 36 63 35 4.1 21 6 10 3
Latvia 43 65 49 5.0 24 9 4 23
Liechtenstein 32 66 .. 5.1 21 8 2 10
Lithuania 37 63 .. 4.3 20 6 13 7
Malta 22 68 56 4.7 10 6 3 14
Moldova, Rep. of 15 .. 37 2.7 5 4 2 2
Monaco 38 69 39 .. 37 11 14 15
Montenegro 12 38 27 3.3 5 5 5 6
Norway 14 35 30 7.1 5 2 4 5
Poland 28 57 37 5.3 23 7 15 8
Portugal 29 52 22 5.0 16 8 7 6
Romania 29 49 36 3.1 7 5 3 7
Russian Fed. (Moscow) 31 37 24 3.8 15 5 2 9
Serbia 20 52 36 4.2 7 3 7 5
Slovak Republic 39 60 50 5.3 27 7 4 10
Slovenia 32 65 53 5.4 23 6 5 20
Sweden 21 38 31 7.0 9 4 8 11
Ukraine 29 54 30 4.2 11 4 2 3
Average 28 57 39 5.1 17 6 6 9
United Kingdom 23 65 52 6.7 25 9 3 10
a)  Having five or more drinks on one occasion. A ’drink’ is a glass/bottle/can of beer (ca 50 cl), a glass/bottle/can of cider (ca 50 cl), 2 glasses/bottles  
of alcopops (ca 50 cl), a glass of wine (ca 15 cl), a glass of spirits (ca 5 cl or a mixed drink).
b) Includes amphetamines, cocaine, crack, ecstasy, LSD or other hallucinogens, heroin and GHB.
c) In order ’to get high’.
d)  Due to lack of comparable 2007-data this comparison is made with 2003-data, highlightning differences greater than 3 percentage points.
Decrease No change Increase No comparison
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Reported use of illicit drugs varies considerably 
across the countries. In the Czech Republic, almost 
half (43 %) of the students admitted to such use, and 
relatively many students (about 39 %) did so in 
France and Monaco. By contrast, only around 6 % 
reported illicit drug use in Bosnia and Herzegovina 
(Republic of Srpska), the Faroe Islands, Moldova, 
Montenegro and Norway. Lower prevalence rates 
are often found in south-eastern Europe, including 
many Balkan countries, and among the Nordic 
countries.
The vast majority of the students who have tried illicit 
drugs have used cannabis. Lifetime cannabis use was 
reported by 17 % of the students in 2011 while 6 % 
had tried one or more of the other drugs included in 
the other-illicit-drugs index. Ecstasy and 
amphetamines share second place (3 % each) while 
cocaine, crack, LSD and heroin were less commonly 
reported (1–2%). Belgium (Flanders), Bulgaria, 
France, Latvia, Monaco and the United Kingdom 
(limited comparability) are the top countries in 2011 
as regards lifetime use of any illicit drug other than 
can nabis, with prevalence rates around 10 %. On 
average, more boys than girls have tried illicit drugs 
other than cannabis: 7 % versus 5 % in 2011. The 
figures are also significantly higher for boys in 14 
countries, even though there is one country, Monaco, 
where significantly more girls reported this.
As mentioned above, cannabis is by far the most 
frequently used illicit drug. Lifetime experience was 
reported by more boys than girls on average, with 
19 % versus 14 % in 2011, and the figures were 
significantly higher for boys in 27 countries. There is 
a huge gap between the top countries — the Czech 
Republic (42 % in 2011), France and Monaco (about 
38% each) — and the bottom ones — Albania, 
Bosnia and Herzegovina (Republic of Srpska), the 
Faroe Islands, Moldova, Montenegro and Norway 
(4–5 % each). Between 2007 and 2011, the 
proportion of stu dents who had tried cannabis 
increased significantly in eleven countries and fell in 
five. The most striking increases happened in France 
and Monaco (8–9 percentage points) while the  
larg est decrease was found in the Russian Federation 
(Moscow) (11 percentage points).
Cannabis use in the past 12 months was reported by 
13 % of all students, with 15 % among boys and 
(13 %) and having had serious prob lems with friends 
or parents (12 % each). Countries where many 
students reported problems related to their alcohol 
consumption include Bulgaria, the Czech Republic, 
Latvia and Slovakia.
Most alcohol-related problems are more common, on 
aver age, among boys. This is most pronounced in the 
cases of ‘phys ical fight’ and ‘trouble with the police’. 
However, for some of the problems the averages are 
about the same for both sexes, including ‘performed 
poorly at school or work’ and having expe rienced 
serious problems with parents or friends.
Illicit drugs
Nearly one in three (29 %) of the students in the 
ESPAD coun tries perceived cannabis to be (fairly or 
very) easily available. However, there are huge 
differences between countries, with the proportion 
ranging from 59 % in the Czech Republic to 6 % in 
Moldova. Boys are slightly more likely than girls to 
consider cannabis to be easily obtainable (33 % 
versus 28 % in 2011), and this tendency is also found 
in most individual coun tries, with significantly higher 
figures for boys in 24 of them. Amphetamines and 
ecstasy are not considered to be as readily available 
as cannabis.
An observed upward trend between 1995 and 
2003 in life time use of illicit drugs came to a halt in 
2007, when the country average was about 2 
percentage points below the one in 2003, and has 
stayed at the same level in 2011. In 1995, 11 % of 
the students reported lifetime use of illicit drugs. The 
correspond ing figure in 2011 was 18 %. Between 
the two most recent survey waves, a significant 
increase was found in eleven countries and a 
significant drop in eight; there is no geographical 
pattern in either case, and both increases and 
decreases can be seen in high-prevalence as well as 
low-prevalence countries.
On average, 21 % of the boys and 15 % of the girls 
have tried illicit drugs at least once during their 
lifetime, according to the 2011 survey. Boys have 
been clearly more likely to have done this in all 
surveys; in the latest wave, significantly higher fig ures 
for boys were found in more than two-thirds of the 
ESPAD countries.
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than boys report non-pre scription use of these 
medical drugs (8 % versus 5 % in 2011) and this 
tendency can also be seen in most countries, with 
girls showing significantly higher figures than boys in 
18 countries in the latest survey. The overall figure 
has been fairly stable be tween 1995 and 2011 (at 
around 7–8 %), even though there were significant 
increases between 2007 and 2011 in three countries 
and decreases in seven.
The average proportion of students having tried 
alcohol to gether with pills in order to get high is 
lower in 2011 (6 %) than it was in 1999 (9 %), and 
this decreasing trend can be found for both sexes. 
Moreover, the smallest gender gap yet is the one 
seen in 2011 (7 % for girls versus 5 % for boys).
Lifetime use of tranquillisers or sedatives without a 
doctor’s prescription, together with mixing alcohol 
and pills, are the only substance-use behaviours that 
have been more common among girls than boys, on 
average, in all five data-collection waves.
Over the years since the first survey in 1995, lifetime-
prevalence rates for the use of inhalants did not 
change very much until 2007, with averages at the 
aggregate level of 8–9 %. However, a slight increase 
from 8 % to 10 % can be seen be tween the two most 
recent surveys. Boys have previously been 1–2 
percentage points above girls, but in 2011 both sexes 
re ported the same proportion (10 %). This has never 
happened before.
In nearly half of the countries (15 out of 32) with 
compa rable data in 2007 and 2011, a significant 
increase in the life time prevalence of inhalants can 
be seen, while a significant drop occurred in seven 
countries. One of the most striking de creases 
happened in the former top country of Cyprus, where 
the proportion of students having tried inhalants was 
reduced by half from 2007 (16 %) to 2011 (8 %). 
There are also pro nounced increases between the 
two latest surveys. One exam ple is Croatia, with an 
increase from 11 % to 28 %, and another is Latvia, 
which went from 13 % to 23 %, making these two the 
top countries in 2011. At the other end, with the 
lowest figure, is Moldova with 2 %.
Polydrug use is analysed in a special chapter of the 
report. The situation in 2011 is relatively stable 
compared with that in 2007. The overall prevalence 
11 % among girls, while use in the past 30 days was 
claimed by 8 % of the boys and 5 % of the girls (7 % 
average). In most countries (27 in 2011), significantly 
more boys than girls have used cannabis in the past 
30 days. In the two highest-prevalence countries 
(France and Monaco), more than one in five students 
report ed cannabis use in the past 30 days, but only 
1–2 % did so in Albania, Bosnia and Herzegovina 
(Republic of Srpska), the Faroe Islands, Moldova, 
Norway and Romania.
The relatively high prevalence of cannabis use 
among young people in Europe raises the question of 
potential negative con sequences for individuals and 
society. An optional module of the questionnaire, the 
CAST scale, was used to estimate the risk of 
cannabis-related problems in the 13 (out of 36) 
ESPAD countries that provided the relevant data. 
Overall, one in three past-year cannabis users (33 %) 
in 2011 was classified as run ning an elevated risk of 
developing cannabis-related problems. The total 
proportion of high-risk users in the overall national 
samples ranged from 1 % to 9 % across countries, 
with an aver age of 5 %.
There are only a few countries where the proportion 
having tried illicit drugs is lower in 2011 than it was 
in 1995. The most prominent case is Ireland, where 
37 % had tried in 1995 but only 19 % in 2011. A 
drop between the same years from 12 % to 7 % can 
be seen in the Faroe Islands, while the figure for the 
United Kingdom decreased from 42 % in 1995 to 
29 % in 2007.
The overall impression is that the increase in the use 
of illic it drugs between 1995 (11 %) and 2003 
(20 %) observed among the ESPAD countries came to 
a halt in 2003, since the average prevalence was 
then 18 % both in 2007 and in 2011.
Other substances
Lifetime non-prescription use of tranquillisers or 
sedatives is most commonly reported in Lithuania, 
Monaco and Poland — where about 14 % of the 
students indicated such use in the 2011 survey — 
while the lowest levels are reported by stu dents from 
the Faroe Islands, Germany (five Bundesländer), 
Liechtenstein, Moldova, the Russian Federation 
(Moscow) and Ukraine (2 %). On average, more girls 
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of polydrug use (involving two or more substances) in 
the total sample from the 29 countries with 
comparable data was close to 9 % in both surveys. 
This is similar to, or even higher than, the figures for 
use of illicit drugs other than cannabis. The 
prevalence of use of three or more substances was 
3.5 % in each survey. Polydrug use is as sociated with 
deviant behaviour, which is here represented by 
having had trouble with the police, having been 
involved in a physical fight, having had sexual 
intercourse without a condom and skipping school.
None of the substances commented in this section 
show any clear geographical pattern.
Final remarks
It is well known that, at the individual level, there is 
often a relationship between the use of different 
substances. In the 2011 data, there are also apparent 
associations between the use of different substances 
at the aggregate country level: it can be concluded 
that in countries where many students report recent 
(past-30-days) alcohol use and heavy episodic 
drinking, more students are likely to report 
experience with illicit drugs and inhalants, and vice 
versa.
Eight key variables give an overview of the 2011 
results per country: cigarette smoking during the past 
30 days, consump tion of any alcoholic beverage 
during the past 30 days, alcohol volume (100 % 
alcohol) consumed on the latest drinking day, heavy 
episodic drinking during the past 30 days, lifetime 
use of marijuana or hashish (cannabis), lifetime use of 
any illicit drug other than cannabis, lifetime non-
prescription use of tranquil lisers or sedatives and 
lifetime use of inhalants.
The individual countries’ prevalence rates for the 
eight key variables are compared with the averages 
for all countries. Countries that often score close to 
the average are Poland and Portugal. Low-prevalence 
countries are Iceland and the neighbouring countries 
of Albania, Bosnia and Herzegovina (Republic of 
Srpska), Moldova and Montenegro. It is more dif ficult 
to identify high-prevalence countries, and no single 
coun try is above average for all measures. However, 
countries that could be mentioned in such a context 
in 2011 are the Czech Republic, Estonia, France, 
Latvia, Monaco and Slovenia. No ob vious 
geographical clusters are apparent.
The overall substance-use trends for all the countries 
with data from all five waves display a slightly 
different develop ment depending on the variable in 
focus. As regards cigarette use in the past 30 days, 
there was a decrease between 1999 and 2007, and 
then unchanged figures in 2011.
A slight reduction since 2003 can be seen for use of 
alcohol during the past 30 days. An upward trend 
was notable for heavy episodic drinking throughout 
1995–2007 (an increase of 9 per centage points), 
mostly explained by increasing prevalence rates 
reported among girls in a number of countries. 
However, this trend seems to have come to a halt 
since the 2011 figures show slight reductions among 
boys as well as girls.
The upward trend between 1995 and 2003 for 
lifetime use of illicit drugs — predominantly cannabis 
— has also come to a halt; the 2007 and 2011 
figures are 3 percentage points below the 2003 
figure. Experience with any illicit drug other than  
can nabis increased from 1995 to 1999, but has been 
fairly stable after that.
Lifetime non-prescription use of tranquillisers or 
sedatives displays hardly any changes at all across 
the five waves. The same is true for inhalants, even 
though the 2011 figure is slightly higher than the 
2007 one.
With one exception — non-prescription use of 
tranquillisers or sedatives — the figures for the key 
variables were higher for boys than for girls in the 
first survey wave. However, this gen der gap had 
more or less disappeared by the time of the 2011 
survey for cigarette and alcohol use during the past 
30 days as well as for lifetime use of inhalants. A 
noticeable reduction in the gender gap can also be 
seen for heavy episodic drinking during the past 30 
days.
However, trends in individual countries diverge from 
the overall impression, as can be seen from the 
colours in the summary table for the eight key 
variables. When it comes to recent changes from 
2007 to 2011, students in Bosnia and Herzegovina 
(Republic of Srpska) show lower figures in 2011 than 
in 2007 for all eight key variables. Other countries 
12
Summary — 2011 ESPAD report
0
25
50
75
20112007200319991995
%
0
5
10
15
20112007200319991995
%
0
5
10
15
20112007200319991995
%
0
25
50
20112007200319991995
%
0
2.0
4.0
6.0
20112007
cl
0
10
20
30
20112007200319991995
%
0
5
10
20112007200319991995
%
0
25
50
20112007200319991995
%
1995–2011. Average 
percentages (if otherwise not 
indicated) for the 14–26 
countries providing trend data.
Cigarette use during the past 30 days. 
Averages for 19 countries. Percentages.
Use of any alcoholic beverage during 
the past 30 days. Averages for 18 
countries.
Proportion reporting having had five or 
more drinks on one occasion during the 
past 30 days. Averages for 14 
countries. (A ‘drink’ is a glass/bottle/
can of beer (ca 50 cl), a glass/bottle/
can of cider (ca 50 cl), 2 glasses/
bottles of alcopops (ca 50 cl), a glass of 
wine (ca 15 cl), a glass of spirits (ca 5 
cl or a mixed drink).
Estimated average alcohol consumption 
during the last alcohol drinking day 
among students reporting any last day 
alcohol consumption. Averages for 26 
countries. (Centilitres 100% alcohol.)
Lifetime use of marijuana or hashish. 
Averages for 19 countries.
Lifetime use of illicit drugs other than 
marijuana or hashish. Averages for 19 
countries. (Includes amphetamines, 
cocaine, crack, ecstasy, LSD or other 
hallucinogens, heroin and (since 2007) 
GHB.)
Lifetime use of tranquillisers or sedatives 
without a doctor’s prescription. 
Averages for 19 countries.
Lifetime use of inhalants. Averages for 
17 countries.
Boys BoysGirls Girls
Boys Boys BoysGirls 19 Girls Girls
Boys Girls Boys Girls Boys Girls
Summary figure Trends for eight key variables by gender. 
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with a relatively large number of reductions include 
Malta with lower figures in 2011 for six variables, 
and Iceland, Norway and the Russian Federation 
(Moscow) with lower figures for five. In the cases of 
Iceland and Norway, this includes all alcohol-related 
variables, while both lifetime use of cannabis and 
lifetime use of any illicit drug other than cannabis 
have decreased in Malta and the Russian Federation 
(Moscow).
In Iceland, this is a continuation of trends seen in 
earlier surveys which have put Iceland in a leading 
position when it comes to low alcohol consumption 
and abstinence from differ ent substances.
Significant increases for six of the eight key variables 
can be seen in Cyprus and for five of them in 
Greece, Hungary and Montenegro. Cypriot students 
reported more use of alcohol and of illicit drugs in 
2011 at the same time as the proportion of them who 
had used inhalants fell to half. The increases in 
Greece and Hungary included heavy episodic 
drinking as well as the quantities consumed on the 
latest drinking day. The in creases in Montenegro 
mainly started from relatively low levels observed in 
the previous survey.
The key variable with the largest number of countries 
(15) reporting significantly higher figures in 2011 than 
in 2007 is in halants. Other variables with a relatively 
large number of coun tries increasing between the 
two most recent surveys include lifetime use of 
cannabis (11) and average alcohol consumption 
during the latest drinking day (10).
The key variables with the largest numbers of 
countries re porting significantly lower figures in 2011 
than in 2007 include alcohol use during the past 30 
days and heavy episodic drink ing during the same 
period (11 countries each).
A look at the whole period from 1995 to 2011 with a 
focus on three variables (heavy episodic drinking, 
lifetime use of cannabis and lifetime use of illicit 
drugs other than cannabis) reveals that, compared 
with 1995, the figures in most coun tries are relatively 
unchanged or higher in 2011. The most pro nounced 
increases in heavy episodic drinking, in terms of  
per centage points, are found in Croatia, Hungary, 
Slovak Republic and Slovenia (21–30 percentage 
points). The largest increases for lifetime cannabis use 
are found in the Czech Republic (with the main 
increase until 2003), Estonia (mainly until 2003) and 
Slovak Republic (even though its 2011 figure is 
significantly lower than the 2007 one) (17–20 
percentage points). With some exceptions, these 
countries are located in the eastern part of Europe.
A reduction between 1995 and 2011 in heavy 
episodic drinking in the past 30 days is mainly found 
in Iceland (23 per centage points), but also in Finland 
(until 2007) and Ukraine (16 percentage points 
each). Lifetime use of cannabis has fall en by 19 
percentage points in Ireland and by 12 in the United 
Kingdom (until 2007). These two are also the only 
countries with significant decreases for lifetime use of 
any illicit drug other than cannabis, with 13 
percentage points in the United Kingdom (from 1995 
to 2007) and 10 in Ireland. With the ex ception of 
Ukraine, these countries are located in western 
Europe.
There are of course more examples of (groups of) 
countries moving in a similar direction than those 
commented on above; one example is the reduced 
alcohol consumption in some of the Nordic countries. 
There are thus a great many additional opportunities 
for analysing ESPAD data, and it is hoped that 
ESPAD researchers, as well as colleagues from other 
countries, will use the ESPAD databases even more in 
the future to ex pand our knowledge about young 
Europeans’ use of different substances.
The full version of the 2011 ESPAD report can be 
found on the following website:   
http://www.espad.org/espad-reports
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Figure 1a 
Lifetime use of illicit drugs (a). 
All students. 2011. 
Percentages.
Figure 1b 
Lifetime use of illicit drugs (a)  
by gender. 2011. Percentages.
(1)  Belgium (Flanders), Bosnia and Herz.  
(RS), Germany (5 Bundesl.) and  
Russian Federation (Moscow):  
limited geographical coverage.
(2)  Spain, United Kingdom and USA:  
limited comparability.
(a)  Includes cannabis, amphetamines, cocaine, 
crack, ecstasy, LSD or other hallucinogens, 
heroin and GHB.
Key figures on drug use
Significant difference 
between boys and girls
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Figure 2a 
Lifetime use of marijuana 
or hashish. All students. 
2011. Percentages.
Figure 2b 
Lifetime use of marijuana or 
hashish by gender. 2011. 
Percentages.
(1)  Belgium (Flanders), Bosnia and Herz.  
(RS), Germany (5 Bundesl.) and  
Russian Federation (Moscow):  
limited geographical coverage.
(2)  Spain, United Kingdom and USA:  
limited comparability.
Significant difference 
between boys and girls
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Figure 3a 
Use of marijuana or 
hashish last 30 days.  
All students. 2011. 
Percentages.
Figure 3b 
Use of marijuana or hashish 
last 30 days by gender. 
2011. Percentages.
(1)  Belgium (Flanders), Bosnia and Herz.  
(RS), Germany (5 Bundesl.) and  
Russian Federation (Moscow):  
limited geographical coverage.
(2)  Spain, United Kingdom and USA:  
limited comparability.
Significant difference 
between boys and girls
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Figure 4a 
Lifetime use of illicit drugs 
other than marijuana or 
hashish (a). All students. 
2011. Percentages.
Figure 4b 
Lifetime use of illicit drugs 
other than marijuana or 
hashish (a) by gender. 2011. 
Percentages.
(1)  Belgium (Flanders), Bosnia and  
Herz. (RS), Germany (5 Bundesl.) and 
Russian Federation (Moscow):  
limited geographical coverage.
(2)  Spain, United Kingdom and USA:  
limited comparability.
(a)  Includes cannabis, amphetamines, 
cocaine, crack, ecstasy, LSD or other 
hallucinogens, heroin and GHB.
(b)  Includes tranquillisers; does not include 
ecstasy or GHB.
Significant difference 
between boys and girls
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Figure 5a 
Lifetime use of 
tranquillisers or sedatives 
without prescription.  
All students. 2011.
Figure 5b 
Lifetime use of tranquillisers 
or sedatives without 
prescription by gender.  
2011. Percentages.
(1)  Belgium (Flanders), Bosnia and Herz.  
(RS), Germany (5 Bundesl.) and  
Russian Federation (Moscow):  
limited geographical coverage.
(2)  Spain, United Kingdom and USA:  
limited comparability.
Significant difference 
between boys and girls
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Figure 6 Lifetime use of marijuana or hashish by country. 1995–2011. Percentages.
Note: Changes within countries between 2007 and 2011 have been tested for sta tistically significant differences with the exception of three countries for which 
it was not possible to conduct significance tests (Denmark, United Kingdom and Norway). Changes below four percentage points between previous data 
collections are not recognised as real changes. Decreases are marked with green, in creases with red, unchanged situations with yellow.
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Figure 7 Lifetime use of illicit drugs other than marijuana or hashish by country. 1995–2011. Percentages.
Note: Changes within countries between 2007 and 2011 have been tested for statistically significant differences with the exception of three countries for which 
it was not possible to conduct significance tests (Denmark, United Kingdom and Norway). Changes below four percentage points between previous data 
collections are not recognised as real changes. Decreases are marked with green, increases with red, unchanged situations with yellow.
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Table 1 Prevalence of polydrug use in 29 countries. 2007 and 2011. Percentages.
2+ substances 3+ substances
2007 2011 2007 2011
Belgium (Flanders) 12.5 12.9 5.4 4.5
Bulgaria 13.0 12.9 5.0 5.2
Croatia 10.2 12.3 3.4 4.3
Cyprus 8.0 11.2 3.0 5.0
Czech Republic 16.2 16.1 6.7 5.9
Estonia 8.3 7.9 3.6 2.5
Finland 4.8 5.8 1.7 2.2
France 15.4 20.1 7.6 7.8
Germany (5 Bundesl.) 11.6 9.8 3.9 3.5
Greece 7.5 7.5 2.3 2.6
Hungary 9.4 10.2 3.6 5.0
Iceland 5.4 4.1 2.2 1.7
Ireland 10.2 6.7 4.6 2.4
Italy 16.1 13.1 7.3 6.2
Latvia 9.7 9.2 3.6 3.6
Lithuania 9.4 7.7 3.1 2.8
Malta 9.9 7.8 4.0 3.3
Monaco 10.2 17.9 5.0 8.3
Montenegro 2.8 4.4 1.1 2.0
Norway 3.0 1.5 1.6 0.6
Poland 8.2 10.7 3.0 4.0
Portugal 7.4 7.1 2.7 3.1
Romania 4.0 5.5 1.1 1.6
Russian Fed. (Moscow) 6.8 6.4 2.4 1.8
Serbia 6.2 5.9 2.0 2.1
Slovak Republic 12.2 9.4 4.7 3.5
Slovenia 10.2 9.8 4.2 4.0
Sweden 3.7 3.9 1.6 1.2
Ukraine 5.8 5.0 1.8 1.9
Note: Polydrug use is defined as use of more than one of the following: tobacco (more than 5 cigarettes per day in the past 30 
days), alcohol (consumption on 10 or more occasions in the past 30 days), cannabis (any use in the past 30 days), other illicit 
drugs (amphetamines, cocaine, crack, heroin and ecstasy as well as LSD or other hallucinogens) (any lifetime use) and 
tranquillisers/sedatives without a prescription (any lifetime use).
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Figure 8
Proportion of high-risk users among those who have 
used cannabis during the past 12 months.
Note: The Cannabis Abuse Screening Test (CAST) scale, was used to estimate the risk of cannabis-related problems in the 13 (out of 36) ESPAD countries that 
provided the relevant data. The CAST sum score ranges from 0 to 6, with a cut-off of 2 or more points indicating high risk cannabis use.
Figure 9
Proportion of high-risk users among all participating 
students in a country.
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About the EMCDDA and ESPAD
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is 
one of the European Union’s decentralised agencies. Established in 1993 and 
based in Lisbon, it is the central source of comprehensive information on drugs 
and drug addiction in Europe.
The EMCDDA collects, analyses and disseminates factual, objective, reliable 
and comparable information on drugs and drug addiction. In doing so, it 
provides its audiences with an evidence-based picture of the drug 
phenomenon at European level. 
The European School Survey Project on Alcohol and Other Drugs (ESPAD) is a 
collaborative effort of independent research teams in more than 40 European 
countries, making it the largest cross-national research project on adolescent 
substance use in the world.
ESPAD was founded in 1993 on the initiative of the Swedish Council for 
Information on Alcohol and Other Drugs (CAN) and with the support of the 
Pompidou Group of the Council of Europe. The first data-collection exercise 
was conducted in 26 countries in 1995. The 2011 ESPAD report presents the 
results from the fifth wave, conducted in 36 countries during 2011.
This multilingual summary is a product of the cooperation framework that 
exists between the EMCDDA and ESPAD. Our common aims include 
broadening access to the information and expertise on alcohol and other drug 
use among school students developed by the ESPAD project and improving 
the availability, quality and comparability of school survey data.
